February 2, 2021
COVID-19 Vaccines Drive Sourcing Increase for Medical Injection Molded Plastics
Medical injection molded plastics demand is increasing due to the COVID-19 vaccine
According to the Thomasnet.com platform, sourcing for medical injection molded plastics has increased 133% since 2019, with a 77% growth over the previous quarter of 2020 alone. With over 90 different vaccines in development or manufacture now, the demand for vials, syringes, and freezers has significantly increased. Plastic injection-molding suppliers have been awarded multi-million dollar contracts from the U.S. Departments of Defense and Health and Human Services to provide additional syringes and vials to meet the increased demand, estimated at 6 billion COVID-19 vaccine doses globally.
Two manufacturers with innovative solutions to the increased demand and related shortages are ApiJect and SiO2. ApiJect uses its Blow-Fill-Seal aseptic technology to create plastic, prefilled syringes. SiO2 has developed a plastic alternative to borosilicate glass vaccine vials by stretch blow molding an injection molded preform into the vial shape and then coating it with a very thin layer of glass. Read more about these innovative solutions here.
Two manufacturers with innovative solutions to the increased demand and related shortages are ApiJect and SiO2. ApiJect uses its Blow-Fill-Seal aseptic technology to create plastic, prefilled syringes. SiO2 has developed a plastic alternative to borosilicate glass vaccine vials by stretch blow molding an injection molded preform into the vial shape and then coating it with a very thin layer of glass. Read more about these innovative solutions here.
© Copyright Injection Molding Group, 2018 - 2021. All rights reserved.
© Copyright Bryan Hauger Consulting Inc. 2014-2021 All rights reserved.